Biomaterials Market by Type of Materials (Metallic, Ceramic, Polymers, Natural) & By Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurological disorders, Tissue Engineering, Ophthalmology) - Global Forecast to 2024

バイオマテリアルの世界市場予測(~2024年)

◆タイトル:Biomaterials Market by Type of Materials (Metallic, Ceramic, Polymers, Natural) & By Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurological disorders, Tissue Engineering, Ophthalmology) - Global Forecast to 2024
◆商品コード:BT 1556
◆調査・発行会社:MarketsandMarkets
◆発行日:2019年6月20日
◆ページ数:239
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥604,550見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥711,550見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥872,050見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、バイオマテリアルの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、材料種類(金属、セラミック、ポリマー、天然)別分析、用途(心血管、整形外科、歯科、形成外科、創傷治癒、神経学的障害、組織工学、眼科学)別分析、バイオマテリアルの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“The biomaterials market is projected to grow at a CAGR of 14.5% during the forecast period (2019–2024).”The biomaterials market is projected to reach USD 207 billion by 2024 from USD 105 billion in 2019, at a CAGR of 14.5%. The growth of the biomaterials market is mainly driven by the increasing funds and grants by government bodies and universities for the development of novel biomaterials. Additionally, the increasing demand for implantable devices, growing demand for biomaterials in plastic surgery and wound healing applications, rising incidence of cardiovascular diseases, and rising awareness and research on regenerative medicine are the factors responsible for the growth of this market. However, limitations of biomaterials-based products and the shortage of skilled surgeons are the major challenges faced by market players.

By type, the polymeric biomaterials segment is expected to register the highest growth during the forecast period.

Based on type, the biomaterials market is segmented into metallic, polymeric, ceramic, and natural biomaterials. The polymeric biomaterials segment is expected to grow at the highest CAGR during the forecast period. This is mainly due to the increasing use of polymers in soft-tissue applications such as plastic surgeries. However, polymers are costly, which can hinder the growth of this market.

By application, the cardiovascular applications segment dominates the biomaterials market

The cardiovascular applications segment accounted for the largest share of the biomaterials market in 2018. The large share of this segment is attributed to the increasing prevalence of cardiovascular diseases, rising geriatric population, the growing number of angiography procedures, and the increasing adoption of cardiac stents, pacemakers, and implantable cardiac defibrillators. According to the American Academy of Orthopedic Surgeons (AAOS), the number of total hip replacement surgeries performed are projected to grow to 635,000 surgeries by 2030.

“APAC is expected to witness the highest growth during the forecast period.”

North America accounted for the largest share of the biomaterials market in 2018, followed by Europe. The large share of the market in North America is attributed to the increase in biomaterial-based research, rising demand for plastic surgeries, growing incidence of cancer, and the rising prevalence of cardiovascular diseases. However, the APAC region is expected to witness the highest CAGR during the forecast period. The growth in this market is attributed to Japan’s growing healthcare industry, increasing geriatric population, rising number of cosmetic and plastic surgeries in India, lucrative medical devices industry, and favorable tax policy in China.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1: 55%, Tier 2: 25%, and Tier 3: 20%
• By Designation: C-level: 43%, Director-level: 32%, and Others: 25%
• By Region: North America: 38%, Europe: 23%, Asia Pacific: 29%, and the Rest of the World: 10%

The prominent players in the biomaterials market are Royal DSM (Netherlands), BASF SE (Germany), Corbion (Netherlands), Carpenter Technology Corporation (US), Evonik Industries (Germany), Berkeley Advanced Biomaterials (US), Cam Bioceramics B.V. (Netherlands), Celanese Corporation (US), CoorsTek Inc. (US), CeramTec (Germany), and GELITA AG (Germany).

Research Coverage:
The report analyzes the biomaterials market and aims at estimating the market size and future growth potential of the biomaterials market and the different segments (type, application, and region). The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product & service offerings, and recent developments.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the biomaterials market.
• Product & Service Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product or service launches in the biomaterials market.
• Market Development: Comprehensive information on lucrative emerging regions.
• Market Diversification: Exhaustive information about new products and services, growing geographies, and recent developments in the biomaterials market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products of the leading players in the biomaterials market.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 22
1.1 OBJECTIVES OF STUDY 22
1.2 MARKET DEFINITION 22
1.2.1 MARKETS COVERED 23
1.2.2 YEARS CONSIDERED FOR THE STUDY 24
1.3 CURRENCY 24
1.4 LIMITATIONS 24
1.5 STAKEHOLDERS 25
2 RESEARCH METHODOLOGY 26
2.1 RESEARCH METHODOLOGY STEPS 26
2.2 RESEARCH DESIGN 27
2.3 SECONDARY DATA 28
2.3.1 PRIMARY DATA 29
2.3.1.1 Key data from primary sources 30
2.3.1.2 Key industry insights 31
2.4 MARKET SIZE ESTIMATION METHODOLOGY 31
2.5 MARKET DATA VALIDATION AND TRIANGULATION 33
2.6 ASSUMPTIONS FOR THE STUDY: 34
3 EXECUTIVE SUMMARY 35
4 PREMIUM INSIGHTS 41
4.1 BIOMATERIALS MARKET OVERVIEW 41
4.2 BIOMATERIALS MARKET, BY TYPE, 2018 (USD BILLION) 42
4.3 BIOMATERIALS MARKET: GEOGRAPHIC SNAPSHOT 43
5 MARKET OVERVIEW 44
5.1 INTRODUCTION 44
5.2 MARKET DYNAMICS 44
5.2.1 DRIVERS 45
5.2.1.1 Increased funds and grants by government bodies and universities for the development of novel biomaterials 45
5.2.1.2 Increasing demand for implantable devices 45
5.2.1.3 Growing demand for biomaterials in plastic surgery and wound healing applications 46
5.2.1.4 Rising incidence of cardiovascular diseases 46
5.2.1.5 Increasing research on regenerative medicine 47

5.2.2 RESTRAINTS 48
5.2.2.1 Stringent clinical & regulatory processes 48
5.2.2.2 Unfavorable healthcare reforms in the US 48
5.2.3 OPPORTUNITIES 48
5.2.3.1 Growing healthcare market in emerging economies 48
5.2.3.2 Increasing number of free-trade agreements 49
5.2.4 CHALLENGES 50
5.2.4.1 Limitations of biomaterial-based products 50
5.2.4.2 Shortage of skilled surgeons 50
6 REGULATORY ASSESSMENT 51
6.1 INTRODUCTION 51
6.2 US 51
6.2.1 INTRODUCTION 51
6.2.2 FDA DEVICE CLASSIFICATION 52
6.2.3 US: REGULATORY APPROVAL TIMELINE ASSESSMENT 54
6.2.4 STRINGENT FDA REGULATIONS GOVERNING PRODUCT APPROVALS 55
6.3 CANADA 55
6.3.1 INTRODUCTION 55
6.3.2 CANADA: REGULATORY APPROVAL TIMELINE ASSESSMENT 57
6.3.3 HEALTH CANADA CLASSIFICATION 57
6.4 EUROPE 58
6.4.1 INTRODUCTION 58
6.4.2 EUROPEAN MEDICAL DEVICE CLASSIFICATION 59
6.4.3 EUROPE: REGULATORY APPROVAL TIMELINE ASSESSMENT 61
6.4.4 EUROPEAN REGULATORY PROCESS TO GET MORE STRINGENT IN FUTURE 61
6.5 JAPAN 62
6.5.1 INTRODUCTION 62
6.5.2 PMDA DEVICE CLASSIFICATION 62
6.5.3 JAPAN: REGULATORY APPROVAL TIMELINE ASSESSMENT 64
6.5.4 REVISION OF THE PHARMACEUTICAL AFFAIRS LAW (PAL) AND IMPLEMENTATION OF THE NEW PMD ACT IN JAPAN 64
6.6 CHINA 65
6.6.1 INTRODUCTION 65
6.6.2 CFDA DEVICE CLASSIFICATION 66
6.6.3 CHINA: REGULATORY APPROVAL TIMELINE ASSESSMENT 67
6.6.4 RISING HURDLES IN THE REGULATORY PROCESS IN CHINA 67
6.7 INDIA 68
6.7.1 INTRODUCTION 68
6.7.2 INDIAN MEDICAL DEVICES CLASSIFICATION 69

6.8 AUSTRALIA 69
6.8.1 INTRODUCTION 69
6.8.2 TGA DEVICE CLASSIFICATION 70
6.8.3 AUSTRALIA: REGULATORY APPROVAL TIMELINE ASSESSMENT 72
7 BIOMATERIALS MARKET, BY TYPE 73
7.1 INTRODUCTION 74
7.2 METALLIC BIOMATERIALS 76
7.2.1 STAINLESS STEEL 77
7.2.1.1 Stainless steel dominates the metallic biomaterials market 77
7.2.2 TITANIUM & TITANIUM ALLOYS 78
7.2.2.1 Rising number of joint replacement procedures will drive the market for titanium biomaterials 78
7.2.3 COBALT-CHROME ALLOYS 79
7.2.3.1 Low cost and excellent corrosion resistance have driven the use of cobalt-chrome alloys 79
7.2.4 GOLD 79
7.2.4.1 Expanding applications of gold nanoparticles to drive the demand for gold biomaterials 79
7.2.5 SILVER 80
7.2.5.1 Toxic properties and low aesthetic appeal likely to limit the use of silver in biomaterial-based products 80
7.2.6 MAGNESIUM 81
7.2.6.1 Biodegradable characteristic of magnesium have stimulated the growth of this market segment 81
7.3 POLYMERIC BIOMATERIALS 82
7.3.1 POLYMETHYLMETHACRYLATE 84
7.3.1.1 PMMA dominates the polymeric biomaterials market 84
7.3.2 POLYETHYLENE 85
7.3.2.1 Wear and tear resistance of polyethylene have made it popular in hip and knee joint replacements 85
7.3.3 POLYESTER 85
7.3.3.1 Biodegradable nature and biocompatibility of polyester will drive its use in various medical applications 85
7.3.4 POLYVINYLCHLORIDE 86
7.3.4.1 Heavy chlorine content of PVC is likely to hamper the market growth 86
7.3.5 SILICONE RUBBER 87
7.3.5.1 Silicone rubbers are non-reactive, stable, and resistant to extreme environments and temperatures 87
7.3.6 NYLON 87
7.3.6.1 Nylon’s low weight, corrosion resistance, and wide applications are expected to drive market demand 87
7.3.7 POLYETHERETHERKETONE 88
7.3.7.1 PEEK is gaining popularity as a viable alternative to metals 88
7.3.8 OTHER POLYMERIC BIOMATERIALS 88
7.4 CERAMICS 89
7.4.1 CALCIUM PHOSPHATE 90
7.4.1.1 Calcium phosphate drives ceramic biomaterial market segment 90
7.4.2 ZIRCONIA 91
7.4.2.1 Bio-inertness and low wear rate of zirconia will boost the market growth 91
7.4.3 ALUMINUM OXIDE 92
7.4.3.1 Increasing use of aluminum oxide in hip replacements and dental implants to drive the market 92
7.4.4 CALCIUM SULFATE 92
7.4.4.1 Fast resorption rate of calcium sulfate is likely to hamper its use 92
7.4.5 CARBON 93
7.4.5.1 Increasing use of carbon nanofibers in regenerative medicine and cancer treatment will drive market growth 93
7.4.6 GLASS 94
7.4.6.1 Rising number of orthopedics and dental procedures likely to drive the demand for glass biomaterials 94
7.5 NATURAL BIOMATERIALS 94
7.5.1 HYALURONIC ACID 97
7.5.1.1 Rising prevalence of osteoarthritis to drive hyaluronic acid market 97
7.5.2 COLLAGEN 97
7.5.2.1 Rising prevalence of target applications to drive growth in collagen market 97
7.5.3 GELATIN 98
7.5.3.1 Low cost of gelatin to drive its market growth 98
7.5.4 FIBRIN 99
7.5.4.1 Fibrin biomaterials were among the first used to prevent bleeding 99
7.5.5 CELLULOSE 99
7.5.5.1 Cellulose find applications in wound healing, skin regeneration, and ophthalmology 99
7.5.6 CHITIN 100
7.5.6.1 Chitin accelerates skin regeneration and possesses high biocompatibility 100
7.5.7 ALGINATES 101
7.5.7.1 Various applications of alginates include wound healing, tissue engineering & regenerative medicine, and drug delivery 101
7.5.8 SILK 101
7.5.8.1 The flexibility, glossiness, and adhesive abilities of silk have made it popular in cosmetic applications 101

8 BIOMATERIALS MARKET, BY APPLICATION 103
8.1 INTRODUCTION 104
8.2 CARDIOVASCULAR 105
8.2.1 CATHETERS 107
8.2.2 STENTS 108
8.2.3 IMPLANTABLE CARDIAC DEFIBRILLATORS 108
8.2.4 PACEMAKERS 109
8.2.5 SENSORS 110
8.2.6 HEART VALVES 110
8.2.7 VASCULAR GRAFTS 111
8.2.8 GUIDEWIRES 112
8.2.9 OTHERS 113
8.3 ORTHOPEDIC 114
8.3.1 JOINT REPLACEMENT 116
8.3.1.1 Knee Replacement 117
8.3.1.2 Hip Replacement 117
8.3.1.3 Shoulder Replacement 118
8.3.1.4 Others 119
8.3.2 VISCOSUPPLEMENTATION 120
8.3.3 BIORESORBABLE TISSUE FIXATION 120
8.3.3.1 Suture anchors 122
8.3.3.2 Interference screws 122
8.3.3.3 Meniscal repair tacks 123
8.3.3.4 Meshes 124
8.3.4 SPINE 124
8.3.4.1 Spinal Fusion Surgeries 125
8.3.4.2 Minimally Invasive Fusion Surgeries 126
8.3.4.3 Motion Preservation & Dynamic Stabilization Surgeries 127
8.3.4.3.1 Pedicle-based rod systems 128
8.3.4.3.2 Interspinous spacers 128
8.3.4.3.3 Artificial Discs 129
8.3.5 FRACTURE FIXATION DEVICES 130
8.3.5.1 Bone plates 131
8.3.5.2 Screws 131
8.3.5.3 Pins 132
8.3.5.4 Rods 133
8.3.5.5 Wires 133
8.3.6 SYNTHETICS BONE GRAFTS 134
8.4 OPHTHALMOLOGY 135
8.4.1 INCREASING PREVALENCE OF EYE DISEASES TO DRIVE MARKET GROWTH 135
8.4.2 CONTACT LENSES 136
8.4.3 INTRAOCULAR LENSES 137
8.4.4 FUNCTIONAL REPLACEMENT OF OCULAR TISSUES 137
8.4.5 SYNTHETIC CORNEAS 138
8.4.6 OTHERS 139
8.5 DENTAL 139
8.5.1 SYNTHETIC DENTAL BIOMATERIALS INCLUDE METALS, CERAMICS, POLYMERS, AND COMPOSITE STRUCTURES 139
8.5.2 DENTAL IMPLANTS 141
8.5.3 DENTAL BONE GRAFTS & SUBSTITUTES 142
8.5.4 DENTAL MEMBRANES 142
8.5.5 TISSUE REGENERATION 143
8.6 PLASTIC SURGERY 144
8.6.1 GROWING NUMBER OF COSMETIC SURGERIES PERFORMED TO DRIVE THE MARKET FOR BIOMATERIALS 144
8.6.2 SOFT-TISSUE FILLERS 145
8.6.3 CRANIOFACIAL SURGERY 146
8.7 WOUND HEALING 147
8.7.1 BIOMATERIALS ARE EXTENSIVELY USED IN VARIOUS WOUND HEALING PRODUCTS 147
8.7.2 WOUND CLOSURE DEVICES 148
8.7.2.1 Sutures 149
8.7.2.2 Staples 150
8.7.3 SURGICAL HEMOSTATS 151
8.7.4 INTERNAL TISSUE SEALANTS 151
8.7.5 ADHESION BARRIERS 152
8.7.6 HERNIA MESHES 152
8.8 TISSUE ENGINEERING 153
8.8.1 INCREASING DEMAND FOR ENHANCED MECHANICAL PERFORMANCE OF TISSUE-ENGINEERED IMPLANTS TO SUPPORT THE GROWTH OF THIS APPLICATION SEGMENT 153
8.8.2 SCAFFOLDS FOR REGENERATIVE MEDICINE 154
8.8.3 NANOMATERIALS FOR BIOSENSING 155
8.8.4 TAILORING OF INORGANIC NANOPARTICLES 156
8.9 NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS 156
8.9.1 THE MAJOR APPLICATION AREAS OF BIOMATERIALS IN CNS DISORDERS INCLUDE SHUNTING, CORTICAL NEURAL PROSTHESIS, AND NEURAL STEM CELL ENCAPSULATION 156
8.9.2 SHUNTING SYSTEMS 158
8.9.3 CORTICAL NEURAL PROSTHETICS 159
8.9.4 HYDROGEL SCAFFOLDS FOR CNS REPAIR 160
8.9.5 NEURAL STEM CELL ENCAPSULATION 160
8.10 OTHER APPLICATIONS 161
8.10.1 DRUG DELIVERY SYSTEMS 162
8.10.2 GASTROINTESTINAL APPLICATIONS 163
8.10.3 BARIATRIC SURGERY 164
8.10.4 URINARY APPLICATIONS 164
9 BIOMATERIALS MARKET, BY REGION 166
9.1 INTRODUCTION 167
9.2 NORTH AMERICA 169
9.2.1 US 171
9.2.1.1 US dominates the North American biomaterials market 171
9.2.2 CANADA 173
9.2.2.1 Increasing incidence of cardiovascular diseases to drive market growth in Canada 173
9.3 EUROPE 174
9.3.1 GERMANY 177
9.3.1.1 Large medical devices market to support the adoption of biomaterials in Germany 177
9.3.2 UK 179
9.3.2.1 Availability of funds and rising cardiovascular procedures to drive the biomaterials market in the UK 179
9.3.3 FRANCE 180
9.3.3.1 Rising aging population and associated diseases to drive the market in France 180
9.3.4 SPAIN 182
9.3.4.1 Increasing research activities on biomaterials to drive the growth in Spain 182
9.3.5 REST OF EUROPE (ROE) 183
9.4 ASIA PACIFIC 185
9.4.1 JAPAN 187
9.4.1.1 Growing medical devices industry to drive market growth 187
9.4.2 CHINA 189
9.4.2.1 Lucrative medical devices industry in China 189
9.4.3 INDIA 190
9.4.3.1 Large population base and growing medical tourism in India to drive the growth of biomaterials 190
9.4.4 REST OF ASIA PACIFIC (ROAPAC) 192
9.5 REST OF THE WORLD (ROW) 194
10 COMPETITIVE LANDSCAPE 196
10.1 OVERVIEW 196
10.2 COMPETITIVE SCENARIO 196
10.2.1 PRODUCT LAUNCHES 197
10.2.2 MERGERS AND ACQUISITIONS 197
10.2.3 EXPANSIONS 198
10.3 COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET) (2018) 198
10.3.1 VISIONARY LEADERS 198
10.3.2 INNOVATORS 199
10.3.3 DYNAMIC DIFFERENTIATORS 199
10.3.4 EMERGING COMPANIES 199
10.4 COMPETITIVE LEADERSHIP MAPPING (START-UP) (2018) 200
10.4.1 PROGRESSIVE COMPANIES 200
10.4.2 STARTING BLOCKS 200
10.4.3 DYNAMIC COMPANIES 200
10.4.4 RESPONSIVE COMPANIES 200
11 COMPANY PROFILES 202
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 ROYAL DSM 202
11.2 BASF SE 205
11.3 CORBION 207
11.4 COVESTRO AG 209
11.5 CARPENTER TECHNOLOGY CORPORATION 212
11.6 EVONIK INDUSTRIES 215
11.7 BERKELEY ADVANCED BIOMATERIALS, INC. 218
11.8 CAM BIOCERAMICS B.V. 219
11.9 CELANESE CORPORATION 220
11.10 COORSTEK INC. 222
11.11 CERAMTEC GMBH 223
11.12 GELITA AG 225

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
12 APPENDIX 226
12.1 DISCUSSION GUIDE 226
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 235
12.3 AVAILABLE CUSTOMIZATIONS 237
12.4 RELATED REPORTS 237
12.5 AUTHOR DETAILS 238

LIST OF TABLES

TABLE 1 IMPORTANT PROPERTIES OF BIOMATERIALS, BY APPLICATION 74
TABLE 2 BIOMATERIALS MARKET, BY TYPE, 2017–2024 (USD BILLION) 75
TABLE 3 METALLIC BIOMATERIALS MARKET, BY TYPE, 2017–2024 (USD BILLION) 76
TABLE 4 METALLIC BIOMATERIALS MARKET, BY REGION, 2017–2024 (USD BILLION) 77
TABLE 5 STAINLESS STEEL BIOMATERIALS MARKET, BY REGION,
2017–2024 (USD MILLION) 77
TABLE 6 TITANIUM & TITANIUM ALLOY BIOMATERIALS MARKET, BY REGION,
2017–2024 (USD MILLION) 78
TABLE 7 COBALT-CHROME ALLOY BIOMATERIALS MARKET, BY REGION,
2017–2024 (USD MILLION) 79
TABLE 8 GOLD BIOMATERIALS MARKET, BY REGION, 2017–2024 (USD MILLION) 80
TABLE 9 SILVER BIOMATERIALS MARKET, BY REGION, 2017–2024 (USD MILLION) 80
TABLE 10 MAGNESIUM BIOMATERIALS MARKET, BY REGION, 2017–2024 (USD MILLION) 81
TABLE 11 APPLICATIONS OF SYNTHETIC POLYMERS 82
TABLE 12 POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2017–2024 (USD BILLION) 83
TABLE 13 POLYMERIC BIOMATERIALS MARKET, BY REGION, 2017–2024 (USD BILLION) 84
TABLE 14 POLYMETHYLMETHACRYLATE BIOMATERIALS MARKET, BY REGION,
2017–2024 (USD MILLION) 84
TABLE 15 POLYETHYLENE BIOMATERIALS MARKET, BY REGION, 2017–2024 (USD MILLION) 85
TABLE 16 POLYESTER BIOMATERIALS MARKET, BY REGION, 2017–2024 (USD MILLION) 86
TABLE 17 POLYVINYLCHLORIDE BIOMATERIALS MARKET, BY REGION,
2017–2024 (USD MILLION) 86
TABLE 18 SILICONE RUBBER BIOMATERIALS MARKET, BY REGION,
2017–2024 (USD MILLION) 87
TABLE 19 NYLON BIOMATERIALS MARKET, BY REGION, 2017–2024 (USD MILLION) 87
TABLE 20 POLYETHERETHERKETONE BIOMATERIALS MARKET, BY REGION,
2017–2024 (USD MILLION) 88
TABLE 21 OTHER POLYMERIC BIOMATERIALS MARKET, BY REGION,
2017–2024 (USD MILLION) 89
TABLE 22 CERAMIC BIOMATERIALS MARKET, BY TYPE, 2017–2024 (USD BILLION) 90
TABLE 23 CERAMIC BIOMATERIALS MARKET, BY REGION, 2017–2024 (USD BILLION) 90
TABLE 24 CALCIUM PHOSPHATE BIOMATERIALS MARKET, BY REGION,
2017–2024 (USD MILLION) 91
TABLE 25 ZIRCONIA BIOMATERIALS MARKET, BY REGION, 2017–2024 (USD MILLION) 91
TABLE 26 ALUMINUM OXIDE BIOMATERIALS MARKET, BY REGION,
2017–2024 (USD MILLION) 92
TABLE 27 CALCIUM SULFATE BIOMATERIALS MARKET, BY REGION,
2017–2024 (USD MILLION) 93
TABLE 28 CARBON BIOMATERIALS MARKET, BY REGION, 2017–2024 (USD MILLION) 93
TABLE 29 GLASS BIOMATERIALS MARKET, BY REGION, 2017–2024 (USD MILLION) 94
TABLE 30 APPLICATIONS OF NATURAL BIOMATERIALS 95
TABLE 31 NATURAL BIOMATERIALS MARKET, BY TYPE, 2017–2024 (USD BILLION) 95
TABLE 32 NATURAL BIOMATERIALS MARKET, BY REGION, 2017–2024 (USD BILLION) 96
TABLE 33 HYALURONIC ACID BIOMATERIALS MARKET, BY REGION,
2017–2024 (USD MILLION) 97
TABLE 34 COLLAGEN BIOMATERIALS MARKET, BY REGION, 2017–2024 (USD MILLION) 98
TABLE 35 GELATIN BIOMATERIALS MARKET, BY REGION, 2017–2024 (USD MILLION) 98
TABLE 36 FIBRIN BIOMATERIALS MARKET, BY REGION, 2017–2024 (USD MILLION) 99
TABLE 37 CELLULOSE BIOMATERIALS MARKET, BY REGION, 2017–2024 (USD MILLION) 100
TABLE 38 CHITIN BIOMATERIALS MARKET, BY REGION, 2017–2024 (USD MILLION) 100
TABLE 39 ALGINATE BIOMATERIALS MARKET, BY REGION, 2017–2024 (USD MILLION) 101
TABLE 40 SILK BIOMATERIALS MARKET, BY REGION, 2017–2024 (USD MILLION) 102
TABLE 41 BIOMATERIALS MARKET, BY APPLICATION, 2017–2024 (USD BILLION) 104
TABLE 42 BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS,
BY PRODUCT, 2017–2024 (USD BILLION) 106
TABLE 43 BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS,
BY REGION, 2017–2024 (USD BILLION) 106
TABLE 44 BIOMATERIALS MARKET FOR CATHETERS, BY REGION, 2017–2024 (USD BILLION) 107
TABLE 45 BIOMATERIALS MARKET FOR STENTS, BY REGION, 2017–2024 (USD BILLION) 108
TABLE 46 BIOMATERIALS MARKET FOR IMPLANTABLE CARDIAC DEFIBRILLATORS,
BY REGION, 2017–2024 (USD BILLION) 109
TABLE 47 BIOMATERIALS MARKET FOR PACEMAKERS, BY REGION,
2017–2024(USD BILLION) 109
TABLE 48 BIOMATERIALS MARKET FOR SENSORS, BY REGION, 2017–2024 (USD BILLION) 110
TABLE 49 BIOMATERIALS USED FOR DIFFERENT VALVE COMPONENTS 111
TABLE 50 BIOMATERIALS MARKET FOR HEART VALVES, BY REGION,
2017–2024 (USD BILLION) 111
TABLE 51 BIOMATERIALS MARKET FOR VASCULAR GRAFTS, BY REGION,
2017–2024 (USD BILLION) 112
TABLE 52 BIOMATERIALS MARKET FOR GUIDEWIRES, BY REGION, 2017–2024(USD BILLION) 112
TABLE 53 BIOMATERIALS MARKET FOR OTHER CARDIOVASCULAR APPLICATIONS,
BY REGION, 2017–2024 (USD BILLION) 113
TABLE 54 BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE,
2017–2024 (USD BILLION) 115
TABLE 55 BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION,
2017–2024 (USD BILLION) 115
TABLE 56 JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE,
2017–2024 (USD BILLION) 116
TABLE 57 JOINT REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2017–2024 (USD BILLION) 116
TABLE 58 KNEE REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2017–2024 (USD MILLION) 117
TABLE 59 HIP REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2017–2024 (USD MILLION) 118
TABLE 60 SHOULDER REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2017–2024 (USD MILLION) 118
TABLE 61 OTHER JOINT REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2017–2024 (USD MILLION) 119
TABLE 62 VISCOSUPPLEMENTATION BIOMATERIALS MARKET, BY REGION,
2017–2024 (USD MILLION) 120
TABLE 63 BIORESORBABLE BIOMATERIALS MARKET, BY PRODUCT,
2017–2024 (USD BILLION) 121
TABLE 64 BIORESORBABLE BIOMATERIALS MARKET, BY REGION, 2017–2024 (USD BILLION) 121
TABLE 65 BIOMATERIALS MARKET FOR SUTURE ANCHORS, BY REGION,
2017–2024(USD MILLION) 122
TABLE 66 BIOMATERIALS MARKET FOR INTERFERENCE SCREWS, BY REGION,
2017–2024 (USD MILLION) 123
TABLE 67 BIOMATERIALS MARKET FOR MENISCAL REPAIR TACKS, BY REGION,
2017–2024(USD MILLION) 123
TABLE 68 BIOMATERIALS MARKET FOR MESHES, BY REGION, 2017–2024(USD MILLION) 124
TABLE 69 BIOMATERIALS MARKET FOR SPINE SURGERIES, BY TYPE,
2017–2024 (USD BILLION) 125
TABLE 70 BIOMATERIALS MARKET FOR SPINE SURGERIES, BY REGION,
2017–2024 (USD BILLION) 125
TABLE 71 BIOMATERIALS MARKET FOR SPINAL FUSION SURGERIES, BY REGION,
2017–2024 (USD MILLION) 126
TABLE 72 BIOMATERIALS MARKET FOR MINIMALLY INVASIVE FUSION SURGERIES,
BY REGION, 2017–2024 (USD MILLION) 126
TABLE 73 BIOMATERIALS MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION SURGERIES, BY PRODUCT, 2017–2024 (USD MILLION) 127
TABLE 74 BIOMATERIALS MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION SURGERIES, BY REGION, 2017–2024 (USD MILLION) 127
TABLE 75 BIOMATERIALS MARKET FOR PEDICLE-BASED ROD SYSTEMS, BY REGION,
2017–2024 (USD MILLION) 128
TABLE 76 BIOMATERIALS MARKET FOR INTERSPINOUS SPACERS, BY REGION,
2017–2024 (USD MILLION) 129
TABLE 77 BIOMATERIALS MARKET FOR ARTIFICIAL DISCS, BY REGION,
2017–2024 (USD MILLION) 129
TABLE 78 BIOMATERIALS MARKET FOR FRACTURE FIXATION DEVICES,
BY TYPE, 2017–2024 (USD BILLION) 130
TABLE 79 BIOMATERIALS MARKET FOR FRACTURE FIXATION DEVICES,
BY REGION, 2017–2024 (USD BILLION) 130
TABLE 80 BIOMATERIALS MARKET FOR BONE PLATES, BY REGION,
2017–2024 (USD MILLION) 131
TABLE 81 BIOMATERIALS MARKET FOR SCREWS, BY REGION, 2017–2024 (USD MILLION) 132
TABLE 82 BIOMATERIALS MARKET FOR PINS, BY REGION, 2017–2024 (USD MILLION) 132
TABLE 83 BIOMATERIALS MARKET FOR RODS, BY REGION, 2017–2024 (USD MILLION) 133
TABLE 84 BIOMATERIALS MARKET FOR WIRES, BY REGION, 2017–2024 (USD MILLION) 133
TABLE 85 BIOMATERIALS MARKET FOR SYNTHETIC BONE GRAFTS, BY REGION,
2017–2024 (USD MILLION) 134
TABLE 86 BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS,
BY TYPE, 2017–2024 (USD BILLION) 135
TABLE 87 BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS,
BY REGION, 2017–2024 (USD BILLION) 135
TABLE 88 BIOMATERIALS MARKET FOR CONTACT LENSES, BY REGION,
2017–2024 (USD BILLION) 136
TABLE 89 BIOMATERIALS MARKET FOR INTRAOCULAR LENSES, BY REGION,
2017–2024 (USD MILLION) 137
TABLE 90 BIOMATERIALS MARKET FOR FUNCTIONAL REPLACEMENT OF OCULAR TISSUES,
BY REGION, 2017–2024 (USD MILLION) 138
TABLE 91 BIOMATERIALS MARKET FOR SYNTHETIC CORNEAS, BY REGION,
2017–2024 (USD MILLION) 138
TABLE 92 BIOMATERIALS MARKET FOR OTHER OPHTHALMOLOGY APPLICATIONS,
BY REGION, 2017–2024 (USD MILLION) 139
TABLE 93 BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY PRODUCT,
2017–2024 (USD BILLION) 139
TABLE 94 BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY REGION,
2017–2024 (USD BILLION) 140
TABLE 95 PERCENTAGE OF INDIVIDUALS WITH UNTREATED DENTAL CARIES IN THE US (2016) 141
TABLE 96 BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY REGION,
2017–2024 (USD BILLION) 141
TABLE 97 BIOMATERIALS MARKET FOR DENTAL BONE GRAFTS & SUBSTITUTES,
BY REGION, 2017–2024 (USD MILLION) 142
TABLE 98 BIOMATERIALS MARKET FOR DENTAL MEMBRANES, BY REGION,
2017–2024 (USD MILLION) 143
TABLE 99 BIOMATERIALS MARKET FOR TISSUE REGENERATION, BY REGION,
2017–2024 (USD MILLION) 143
TABLE 100 BIOMATERIALS MARKET FOR PLASTIC SURGERY, BY APPLICATION,
2017–2024 (USD BILLION) 144
TABLE 101 BIOMATERIALS MARKET FOR PLASTIC SURGERY, BY REGION,
2017–2024 (USD BILLION) 144
TABLE 102 BIOMATERIALS MARKET FOR SOFT-TISSUE FILLERS, BY REGION,
2017–2024 (USD MILLION) 146
TABLE 103 BIOMATERIALS MARKET FOR CRANIOFACIAL SURGERY, BY REGION,
2017–2024 (USD BILLION) 147
TABLE 104 BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY PRODUCT, 2017–2024 (USD BILLION) 147
TABLE 105 BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY REGION,
2017–2024 (USD BILLION) 148
TABLE 106 BIOMATERIALS MARKET FOR WOUND CLOSURE DEVICES, BY PRODUCT,
2017–2024 (USD MILLION) 149
TABLE 107 BIOMATERIALS MARKET FOR WOUND CLOSURE DEVICES, BY REGION,
2017–2024 (USD MILLION) 149
TABLE 108 BIOMATERIALS MARKET FOR SUTURES, BY REGION, 2017–2024 (USD MILLION) 150
TABLE 109 BIOMATERIALS MARKET FOR STAPLES, BY REGION, 2017–2024 (USD MILLION) 150
TABLE 110 BIOMATERIALS MARKET FOR SURGICAL HEMOSTATS, BY REGION,
2017–2024 (USD MILLION) 151
TABLE 111 BIOMATERIALS MARKET FOR INTERNAL TISSUE SEALANTS, BY REGION,
2017–2024 (USD MILLION) 151
TABLE 112 BIOMATERIALS MARKET FOR ADHESION BARRIERS, BY REGION,
2017–2024 (USD MILLION) 152
TABLE 113 BIOMATERIALS MARKET FOR HERNIA MESHES, BY REGION,
2017–2024 (USD MILLION) 153
TABLE 114 TISSUE ENGINEERING BIOMATERIALS MARKET, BY APPLICATION,
2017–2024 (USD BILLION) 153
TABLE 115 TISSUE ENGINEERING BIOMATERIALS MARKET, BY REGION,
2017–2024 (USD BILLION) 154
TABLE 116 TISSUE ENGINEERING BIOMATERIALS MARKET FOR SCAFFOLDS FOR REGENERATIVE MEDICINE, BY REGION, 2017–2024 (USD MILLION) 155
TABLE 117 TISSUE ENGINEERING BIOMATERIALS MARKET FOR NANOMATERIALS FOR BIOSENSING, BY REGION, 2017–2024 (USD MILLION) 155
TABLE 118 TISSUE ENGINEERING BIOMATERIALS MARKET FOR TAILORING OF INORGANIC NANOPARTICLES, BY REGION, 2017–2024 (USD MILLION) 156
TABLE 119 BIOMATERIALS MARKET FOR NEUROLOGICAL/CNS APPLICATIONS,
BY PRODUCT, 2017–2024 (USD MILLION) 157
TABLE 120 BIOMATERIALS MARKET FOR NEUROLOGICAL/CNS APPLICATIONS,
BY REGION, 2017–2024 (USD MILLION) 157
TABLE 121 BIOMATERIALS MARKET FOR SHUNTING SYSTEMS, BY REGION,
2017–2024 (USD MILLION) 159
TABLE 122 BIOMATERIALS MARKET FOR CORTICAL NEURAL PROSTHETICS,
BY REGION, 2017–2024 (USD MILLION) 159
TABLE 123 BIOMATERIALS MARKET FOR HYDROGEL SCAFFOLDS FOR CNS REPAIR,
BY REGION, 2017–2024 (USD MILLION) 160
TABLE 124 BIOMATERIALS MARKET FOR NEURAL STEM CELL ENCAPSULATION,
BY REGION, 2017–2024 (USD MILLION) 161
TABLE 125 OTHER BIOMATERIAL APPLICATIONS MARKET, BY TYPE,
2017–2024 (USD MILLION) 161
TABLE 126 OTHER BIOMATERIAL APPLICATIONS MARKET, BY REGION,
2017–2024 (USD MILLION) 162
TABLE 127 BIOMATERIALS MARKET FOR DRUG DELIVERY SYSTEMS, BY REGION,
2017–2024 (USD MILLION) 163
TABLE 128 BIOMATERIALS MARKET FOR GASTROINTESTINAL APPLICATIONS,
BY REGION, 2017–2024 (USD MILLION) 163
TABLE 129 BIOMATERIALS MARKET FOR BARIATRIC SURGERY, BY REGION,
2017–2024 (USD MILLION) 164
TABLE 130 BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY REGION,
2017–2024 (USD MILLION) 165
TABLE 131 BIOMATERIALS MARKET, BY REGION, 2017–2024 (USD BILLION) 167
TABLE 132 NORTH AMERICA: BIOMATERIALS MARKET, BY COUNTRY,
2017–2024 (USD BILLION) 170
TABLE 133 NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE, 2017–2024 (USD BILLION) 170
TABLE 134 NORTH AMERICA: BIOMATERIALS MARKET, BY APPLICATION,
2017–2024 (USD BILLION) 170
TABLE 135 US: BIOMATERIALS MARKET, BY TYPE, 2017–2024 (USD BILLION) 172
TABLE 136 US: BIOMATERIALS MARKET, BY APPLICATION, 2017–2024 (USD BILLION) 172
TABLE 137 CANADA: BIOMATERIALS MARKET, BY TYPE, 2017–2024 (USD BILLION) 173
TABLE 138 CANADA: BIOMATERIALS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 174
TABLE 139 EUROPE: BIOMATERIALS MARKET, BY COUNTRY, 2017–2024 (USD BILLION) 176
TABLE 140 EUROPE: BIOMATERIALS MARKET, BY TYPE, 2017–2024 (USD BILLION) 176
TABLE 141 EUROPE: BIOMATERIALS MARKET, BY APPLICATION, 2017–2024 (USD BILLION) 177
TABLE 142 GERMANY: BIOMATERIALS MARKET, BY TYPE, 2017–2024 (USD BILLION) 178
TABLE 143 GERMANY: BIOMATERIALS MARKET, BY APPLICATION, 2017–2024 (USD BILLION) 178
TABLE 144 UK: BIOMATERIALS MARKET, BY TYPE, 2017–2024 (USD BILLION) 179
TABLE 145 UK: BIOMATERIALS MARKET, BY APPLICATION, 2017–2024 (USD BILLION) 180
TABLE 146 FRANCE: BIOMATERIALS MARKET, BY TYPE, 2017–2024 (USD BILLION) 181
TABLE 147 FRANCE: BIOMATERIALS MARKET, BY APPLICATION, 2017–2024 (USD BILLION) 181
TABLE 148 SPAIN: BIOMATERIALS MARKET, BY TYPE, 2017–2024 (USD BILLION) 182
TABLE 149 SPAIN: BIOMATERIALS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 183
TABLE 150 ROE: BIOMATERIALS MARKET, BY TYPE, 2017–2024 (USD BILLION) 184
TABLE 151 ROE: BIOMATERIALS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 184
TABLE 152 APAC: BIOMATERIALS MARKET, BY COUNTRY/REGION, 2017–2024 (USD BILLION) 186
TABLE 153 APAC: BIOMATERIALS MARKET, BY TYPE, 2017–2024 (USD BILLION) 186
TABLE 154 APAC: BIOMATERIALS MARKET, BY APPLICATION, 2017–2024 (USD BILLION) 187
TABLE 155 JAPAN: BIOMATERIALS MARKET, BY TYPE, 2017–2024 (USD BILLION) 188
TABLE 156 JAPAN: BIOMATERIALS MARKET, BY APPLICATION, 2017–2024 (USD BILLION) 188
TABLE 157 CHINA: BIOMATERIALS MARKET, BY TYPE, 2017–2024 (USD BILLION) 189
TABLE 158 CHINA: BIOMATERIALS MARKET, BY APPLICATION, 2017–2024 (USD BILLION) 190
TABLE 159 INDIA: BIOMATERIALS MARKET, BY TYPE, 2017–2024 (USD BILLION) 191
TABLE 160 INDIA: BIOMATERIALS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 191
TABLE 161 ROAPAC: BIOMATERIALS MARKET, BY TYPE, 2017–2024 (USD BILLION) 192
TABLE 162 ROAPAC: BIOMATERIALS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 193
TABLE 163 ROW: BIOMATERIALS MARKET, BY TYPE, 2017–2024 (USD BILLION) 195
TABLE 164 ROW: BIOMATERIALS MARKET, BY APPLICATION, 2017–2024 (USD BILLION) 195
TABLE 165 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, BY COMPANIES
(2015–2019) 196
TABLE 166 PRODUCT LAUNCHES BY COMPANIES (2015–2019) 197
TABLE 167 MERGER AND ACQUISITIONS BY COMPANIES (2015–2018) 197
TABLE 168 EXPANSIONS BY COMPANIES (2015–2019) 198


LIST OF FIGURES

FIGURE 1 GLOBAL BIOMATERIALS MARKET SEGMENTATION 23
FIGURE 2 RESEARCH METHODOLOGY: BIOMATERIALS MARKET 26
FIGURE 3 BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 29
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 32
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 32
FIGURE 6 DATA TRIANGULATION METHODOLOGY 33
FIGURE 7 BIOMATERIALS MARKET, BY TYPE, 2019 VS 2024 (USD BILLION) 35
FIGURE 8 METALLIC BIOMATERIALS MARKET, BY TYPE, 2019 VS 2024 (USD BILLION) 36
FIGURE 9 CERAMIC BIOMATERIALS MARKET, BY TYPE, 2019 VS 2024 (USD BILLION) 36
FIGURE 10 POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2019 VS 2024 (USD BILLION) 37
FIGURE 11 NATURAL BIOMATERIALS MARKET, BY TYPE, 2019 VS 2024 (USD BILLION) 38
FIGURE 12 PLASTIC SURGERY SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 39
FIGURE 13 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE BIOMATERIALS MARKET 40
FIGURE 14 INCREASING DEMAND FOR IMPLANTABLE DEVICES TO DRIVE THE GROWTH OF THE MARKET 41
FIGURE 15 METALLIC BIOMATERIALS TO DOMINATE THE NORTH AMERICAN BIOMATERIALS MARKET DURING THE FORECAST PERIOD 42
FIGURE 16 ASIA PACIFIC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 43
FIGURE 17 BIOMATERIALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 44
FIGURE 18 US: REGULATORY APPROVAL PROCESS 53
FIGURE 19 REGULATORY APPROVAL TIMELINE IN THE US 54
FIGURE 20 CANADA: REGULATORY APPROVAL PROCESS 56
FIGURE 21 REGULATORY APPROVAL TIMELINE IN CANADA 57
FIGURE 22 EUROPE: REGULATORY APPROVAL PROCESS 60
FIGURE 23 REGULATORY APPROVAL TIMELINE IN EUROPE 61
FIGURE 24 JAPAN: REGULATORY APPROVAL PROCESS 63
FIGURE 25 REGULATORY APPROVAL TIMELINE IN JAPAN 64
FIGURE 26 CHINA: REGULATORY APPROVAL PROCESS 66
FIGURE 27 REGULATORY APPROVAL TIMELINE IN CHINA 67
FIGURE 28 INDIA: REGULATORY APPROVAL PROCESS 68
FIGURE 29 AUSTRALIA: REGULATORY APPROVAL PROCESS 71
FIGURE 30 REGULATORY APPROVAL TIMELINE IN AUSTRALIA 72
FIGURE 31 POLYMERIC BIOMATERIALS TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 75
FIGURE 32 TITANIUM AND TITANIUM ALLOYS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 76
FIGURE 33 PMMA SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 83
FIGURE 34 CERAMIC BIOMATERIALS MARKET, BY TYPE, 2017 VS 2024 89
FIGURE 35 HYALURONIC ACID SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 96
FIGURE 36 PLASTIC SURGERY SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 105
FIGURE 37 STENTS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 107
FIGURE 38 JOINT REPLACEMENT TO DOMINATE THE ORTHOPEDIC BIOMATERIALS MARKET DURING THE FORECAST PERIOD 114
FIGURE 39 CONTACT LENSES SEGMENT TO DOMINATE THE BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS DURING THE FORECAST PERIOD 136
FIGURE 40 DENTAL IMPLANTS SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE DENTAL BIOMATERIALS MARKET DURING THE FORECAST PERIOD 140
FIGURE 41 SOFT-TISSUE FILLERS SEGMENT WILL CONTINUE TO DOMINATE THE BIOMATERIALS MARKET FOR PLASTIC SURGERY IN 2024 145
FIGURE 42 INTERNAL TISSUE SEALANTS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 148
FIGURE 43 SCAFFOLDS FOR REGENERATIVE MEDICINE SEGMENT TO DOMINATE THE TISSUE ENGINEERING BIOMATERIALS MARKET IN 2018 154
FIGURE 44 CORTICAL NEURAL PROSTHETICS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 158
FIGURE 45 BIOMATERIALS MARKET, BY REGION, 2019 VS. 2024 (USD BILLION) 168
FIGURE 46 NORTH AMERICA: BIOMATERIALS MARKET SNAPSHOT 169
FIGURE 47 EUROPE: BIOMATERIALS MARKET SNAPSHOT 175
FIGURE 48 ASIA PACIFIC: BIOMATERIALS MARKET SNAPSHOT 185
FIGURE 49 ROW: BIOMATERIALS MARKET SNAPSHOT 194
FIGURE 50 KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS 196
FIGURE 51 COMPETITIVE LEADERSHIP MAPPING: BIOMATERIALS MARKET 199
FIGURE 52 COMPETITIVE LEADERSHIP MAPPING: BIOMATERIALS MARKET 201
FIGURE 53 ROYAL DSM: COMPANY SNAPSHOT 202
FIGURE 54 BASF: COMPANY SNAPSHOT 205
FIGURE 55 CORBION: COMPANY SNAPSHOT 207
FIGURE 56 COVESTRO: COMPANY SNAPSHOT 209
FIGURE 57 CARPENTER TECHNOLOGY: COMPANY SNAPSHOT 212
FIGURE 58 EVONIK INDUSTRIES: COMPANY SNAPSHOT 215
FIGURE 59 CELANESE CORPORATION: COMPANY SNAPSHOT 220
FIGURE 60 CERAMTEC: COMPANY SNAPSHOT 223


★調査レポート[バイオマテリアルの世界市場予測(~2024年)] ( Biomaterials Market by Type of Materials (Metallic, Ceramic, Polymers, Natural) & By Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurological disorders, Tissue Engineering, Ophthalmology) - Global Forecast to 2024 / BT 1556) 販売に関する免責事項
[バイオマテリアルの世界市場予測(~2024年)] ( Biomaterials Market by Type of Materials (Metallic, Ceramic, Polymers, Natural) & By Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurological disorders, Tissue Engineering, Ophthalmology) - Global Forecast to 2024 / BT 1556) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆